Ad is loading...
ABSI
Price
$2.55
Change
-$0.13 (-4.85%)
Updated
Nov 21 closing price
117 days until earnings call
FATE
Price
$2.07
Change
-$0.15 (-6.76%)
Updated
Nov 21 closing price
101 days until earnings call
Ad is loading...

ABSI vs FATE

Header iconABSI vs FATE Comparison
Open Charts ABSI vs FATEBanner chart's image
Absci
Price$2.55
Change-$0.13 (-4.85%)
Volume$1.67M
CapitalizationN/A
Fate Therapeutics
Price$2.07
Change-$0.15 (-6.76%)
Volume$2.01M
CapitalizationN/A
ABSI vs FATE Comparison Chart
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ABSI vs. FATE commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Buy and FATE is a Sell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (ABSI: $2.55 vs. FATE: $2.07)
Brand notoriety: ABSI and FATE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 159% vs. FATE: 105%
Market capitalization -- ABSI: $292.88M vs. FATE: $235.76M
ABSI [@Biotechnology] is valued at $292.88M. FATE’s [@Biotechnology] market capitalization is $235.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileFATE’s FA Score has 1 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • FATE’s FA Score: 1 green, 4 red.
According to our system of comparison, ABSI is a better buy in the long-term than FATE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 5 TA indicator(s) are bullish while FATE’s TA Score has 4 bullish TA indicator(s).

  • ABSI’s TA Score: 5 bullish, 5 bearish.
  • FATE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ABSI and FATE are a good buy in the short-term.

Price Growth

ABSI (@Biotechnology) experienced а -15.42% price change this week, while FATE (@Biotechnology) price change was -0.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

ABSI is expected to report earnings on Mar 19, 2025.

FATE is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABSI($293M) has a higher market cap than FATE($236M). ABSI YTD gains are higher at: -39.286 vs. FATE (-44.652). ABSI has higher annual earnings (EBITDA): -83.27M vs. FATE (-177.57M). FATE has more cash in the bank: 297M vs. ABSI (127M). ABSI has less debt than FATE: ABSI (12M) vs FATE (99M). FATE has higher revenues than ABSI: FATE (13.4M) vs ABSI (4.21M).
ABSIFATEABSI / FATE
Capitalization293M236M124%
EBITDA-83.27M-177.57M47%
Gain YTD-39.286-44.65288%
P/E RatioN/AN/A-
Revenue4.21M13.4M31%
Total Cash127M297M43%
Total Debt12M99M12%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABSIFATE
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
89%
Bullish Trend 19 days ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBHIX24.420.20
+0.83%
Saratoga Health & Biotechnology I
MUEUX39.870.26
+0.66%
MFS Blended Research Core Equity R4
LMGRX60.840.24
+0.40%
ClearBridge International Growth R
CGOLX20.080.06
+0.30%
Columbia International Div Inc Adv
EMECX10.60N/A
N/A
Ashmore Emerging Markets Equity C

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with PLRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
-4.85%
PLRX - ABSI
48%
Loosely correlated
+0.94%
RXRX - ABSI
47%
Loosely correlated
-4.80%
CRSP - ABSI
46%
Loosely correlated
-2.05%
PRME - ABSI
46%
Loosely correlated
-0.67%
FATE - ABSI
45%
Loosely correlated
-6.76%
More

FATE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with ALLO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
-6.76%
ALLO - FATE
55%
Loosely correlated
+2.93%
ABCL - FATE
54%
Loosely correlated
+1.87%
INZY - FATE
53%
Loosely correlated
-3.58%
NTLA - FATE
53%
Loosely correlated
+5.18%
BEAM - FATE
52%
Loosely correlated
-3.72%
More